SLC25A17 [The Human Chemical-Genetic Interaction Map Project]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
======= SLC25A17 =======


== Gene Information ==
  * **<color #00a2e8>Official Symbol</color>**: SLC25A17
  * **<color #00a2e8>Official Name</color>**: solute carrier family 25 member 17
  * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A
  * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10478|10478]]
  * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/O43808|O43808]]
  * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=SLC25A17&organism=9606|BioGRID]]
  * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC25A17|Open PubMed]]
  * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/606795|Open OMIM]]

== Function Summary ==
  * **<color #00a2e8>Entrez Summary</color>**: N/A
  * **<color #00a2e8>UniProt Summary</color>**:  Peroxisomal transporter for multiple cofactors like coenzyme A (CoA), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN) and nucleotide adenosine monophosphate (AMP), and to a lesser extent for nicotinamide adenine dinucleotide (NAD(+)), adenosine diphosphate (ADP) and adenosine 3',5'- diphosphate (PAP). May catalyze the transport of free CoA, FAD and NAD(+) from the cytosol into the peroxisomal matrix by a counter- exchange mechanism. Inhibited by pyridoxal 5'-phosphate and bathophenanthroline in vitro. {ECO:0000269|PubMed:12445829, ECO:0000269|PubMed:22185573}.

<button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button>
<button type='primary' size='sm' modal='GO_terms'>GO Terms</button>


<modal id='Pfam_Domains' size='lg' title='Pfam Domains'>
|Mito carr|
</modal>

<modal id='GO_terms' size='lg' title='GO Terms'>
|adenine nucleotide transmembrane transporter activity|
|NAD transmembrane transport|
|FMN transmembrane transporter activity|
|NAD transmembrane transporter activity|
|ADP transmembrane transporter activity|
|AMP transmembrane transporter activity|
|coenzyme A transport|
|AMP transport|
|adenosine 3,5-bisphosphate transmembrane transport|
|FAD transmembrane transporter activity|
|NAD transport|
|FAD transmembrane transport|
|coenzyme A transmembrane transporter activity|
|coenzyme A transmembrane transport|
|ATP transmembrane transporter activity|
|ADP transport|
|nucleotide transmembrane transport|
|purine-containing compound transmembrane transport|
|coenzyme transport|
|fatty acid alpha-oxidation|
|ATP transport|
|integral component of peroxisomal membrane|
|adenine nucleotide transport|
|purine ribonucleotide transport|
|purine nucleotide transport|
|nucleotide transport|
|organic cation transport|
|cofactor transport|
|peroxisomal membrane|
|fatty acid beta-oxidation|
|carbohydrate derivative transport|
|fatty acid transport|
|fatty acid oxidation|
|lipid oxidation|
|fatty acid catabolic process|
|chaperone binding|
|peroxisome|
|monocarboxylic acid catabolic process|
|organophosphate ester transport|
|monocarboxylic acid transport|
|drug transport|
|cellular lipid catabolic process|
|lipid modification|
|nucleobase-containing compound transport|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|anion transmembrane transport|
|organic acid transport|
|carboxylic acid transport|
|lipid transport|
|lipid catabolic process|
|lipid localization|
|fatty acid metabolic process|
|small molecule catabolic process|
|organic anion transport|
|monocarboxylic acid metabolic process|
|anion transport|
|cation transport|
|carboxylic acid metabolic process|
|ion transmembrane transport|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|response to drug|
|organic acid metabolic process|
|lipid metabolic process|
|transmembrane transport|
|ion transport|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|nitrogen compound transport|
|membrane|
</modal>
\\

 === CRISPR Data ===
<button type='default' size='small' modal='Compound_Hit'>Compound Hit</button>
<button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button>
<button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button>

<modal id='Compound_Hit' size='lg' title='Compound Hit'>
No hits were found.
</modal>

<modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'>
No correlation found to any other genes in chemogenomics.
</modal>

<modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'>
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
</modal>

== Essentiality in NALM6  ==
    * **<color #00a2e8>Essentiality Rank</color>**: 6858
    * **<color #00a2e8>Expression level (log2 read counts)</color>**: 4.9 
<button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button>
<modal id='Dist_expr' size='lg' title='SLC25A17 Expression in NALM6 Cells: 4.9'>
{{:chemogenomics:nalm6 dist.png?nolink |}}
</modal>